UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-06-09 | -0.10 | -0.10 |
| Q2 2022 | 2022-03-14 | -0.05 | -0.05 |
| Q1 2022 | 2021-12-15 | -0.05 | -0.05 |
| Q1 2020 | 2021-12-15 | 0.00 | 0.00 |
| Q4 2021 | 2021-10-12 | 0.07 | 0.07 |
| Q4 2019 | 2021-10-12 | 0.00 | 0.00 |
| Q3 2021 | 2021-06-09 | 0.04 | 0.04 |
| Q2 2019 | 2021-03-15 | 0.00 | 0.00 |
| Q1 2021 | 2020-12-09 | 0.01 | 0.01 |
| Q4 2020 | 2020-10-13 | -0.07 | -0.07 |
| 8899-03-09 | ||||
| 7829-03-21 | ||||
| 4975-04-02 | ||||
| 3914-03-19 | ||||
| 2106-03-31 | ||||
| 2011-10-18 | Reiterated | Rodman & Renshaw | Mkt Outperform | $7 to $5 |
| 2009-09-23 | Initiated | Rodman & Renshaw | Mkt Outperform | $14 |
| 2007-09-13 | Initiated | Lazard Capital | Buy | $19 |
| 1970-01-01 | ||||
| 1762-02-26 |
| 8899-03-09 | ||||
| 7829-03-21 | ||||
| 4975-04-02 | ||||
| 3914-03-19 | ||||
| 2106-03-31 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ENZ 49 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| HARBERT FUND ADVISORS, INC. | 5.18M |
| RENAISSANCE TECHNOLOGIES LLC | 2.91M |
| Roumell Asset Management, LLC | 2.39M |
| Vanguard Group, Inc | 1.77M |
| DIMENSIONAL FUND ADVISORS LP | 1.59M |
| BlackRock Institutional Trust Company, N.A. | 1.53M |
| BlackRock Inc. | 1.47M |
| BlackRock Fund Advisors | 1.28M |
| FULLER & THALER ASSET MANAGEMENT, INC. | 0.97M |
| Potomac Capital Management, Inc. | 0.56M |
| MORGAN STANLEY | 0.39M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.36M |
| BRIDGEWAY CAPITAL MANAGEMENT INC | 0.32M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.32M |
| RBF Capital, LLC | 0.25M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| RABBANI ELAZAR Chairman and CEO | 4.20% (1838668) | ENZ / |
| RABBANI SHAHRAM K Treasurer, Secretary | 3.51% (1539392) | ENZ / |
| WEINER BARRY W President and CFO | 2.94% (1290485) | ENZ / |
| Perlysky Dov | 1.56% (684237) | ENZ / |
| BORTZ GREGORY M. | 0.67% (292875) | ENZ / |
| BASS HERBERT B Senior Vice President, Finance | 0.48% (209359) | ENZ / |
| SIAS JOHN B | 0.39% (173087) | ENZ / |
| KELKER NORMAN E Senior Vice President | 0.25% (110855) | ENZ / |
| GOLDBERG DAVID C VP, Business Development | 0.20% (87316) | ADAT / ENZ / |
| THALENFELD BARBARA E VP, Corporate Development | 0.13% (55550) | ENZ / |
| Crescenzo Andrew R. Senior Vice President, Finance | 0.12% (52452) | ENZ / |
| O'Brien James Michael SVP of Finance | 0.06% (28187) | ENZ / |
| Whiteley Andrew P VP BusDev-COO Enzo Lif Sci Inc | 0.06% (27213) | ENZ / |
| BALEZENTIS CARL W President, Enzo Life Sciences | 0.06% (25950) | ENZ / |
| DELUCCA JOHN | 0.04% (18589) | ENDP / ENZ / MWRX / |
| KRENITSKY KEVIN President, Enzo Clinical Labs | 0.04% (17600) | ENZ / FMI / |
| FISCHETTE CHRISTINE Pres., Enzo Therapeutics, Inc. | 0.03% (11500) | ENZ / |
| Kent Stephen B H | 0.02% (9654) | ENZ / |
UM